Biocatalysed concurrent production of enantioenriched compounds through parallel interconnected kinetic asymmetric transformations by Rioz Martínez, Ana et al.
CREATED USING THE RSC ARTICLE TEMPLATE (VER. 3.1) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS 
ARTICLE TYPE www.rsc.org/xxxxxx  |  XXXXXXXX 
This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  1 
Biocatalysed Concurrent Production of Enantioenriched Compounds 












Daniel E. Torres Pazmiño,
b
 Marco W. Fraaije
b
 and Vicente Gotor*
a
 
Received (in XXX, XXX) Xth XXXXXXXXX 200X, Accepted Xth XXXXXXXXX 200X 5 
First published on the web Xth XXXXXXXXX 200X 
DOI: 10.1039/b000000x 
Parallel interconnected kinetic asymmetric transformations were performed in order to obtain 
enantioenriched derivatives starting from a set of racemic or prochiral compounds. Thus, in a one-
pot reaction using two redox biocatalysts (a BVMO and an ADH) and a catalytic amount of 10 
cofactor that acts as a mediator, enantioenriched ketones, sulfoxides, and sec-alcohols were 
concurrently obtained in a strict parallel way minimising the quantity of reagents employed. By 
selecting the appropriate biocatalysts, this methodology is a potential tool for performing 
stereodivergent transformations. 
Introduction 15 
Enantioenriched alcohols, ketones, and esters are important 
synthons in the pharmaceutical and (agro)chemical industry.1 
To obtain them, several routes catalysed by (organo)metallic 
complexes have extensively been explored.2 Enantiopure 
sulfoxides play an important role as chiral auxiliaries as well 20 
as in medicinal and pharmaceutical chemistry.3 Different 
methodologies have been described for the preparation of 
these derivatives as, for instance, the asymmetric oxidation of 
the corresponding prochiral sulfides.4 
In the last few years, several biocatalytic processes using 25 
redox enzymes such alcohol dehydrogenases (ADHs) and 
Baeyer-Villiger monooxygenases (BVMOs) have been 
developed due to the high selectivities obtained employing 
mild and environmental friendly conditions.5 The synthesis of 
chiral secondary alcohols via reduction of ketones or 30 
oxidative kinetic resolutions of rac-alcohols using ADHs have 
attracted attention.6 Additionally, BVMOs represent a very 
promising family of redox biocatalysts which are able to 
catalyse the oxidation of carbonyl compounds as well as 
certain heteroatoms with excellent regio- and/or enantio-35 
selectivities.7 In despite of all the advantages provided by 
these enzymes, their implementation at industrial scale usually 
remains impeded due to the high costs related to the 
nicotinamide cofactor needed by these redox biocatalysts. 
Therefore, various chemical,8,9 electrochemical,10 and 40 
enzymatic11 methods have been explored in order to 
regenerate the coenzymes NAD(P)H or NAD(P)+. However, 
these methodologies have several drawbacks such as harmful 
effects on the biocatalyst, high costs and loss of material, 
which diminishes the atom efficiency12 of the process. 45 
In nature a huge number of chemically interconnected 
processes concurrently take place and the products are shared 
by different metabolic routes, forming a complex and 
effective metabolic network.13 For instance, redox trans-
formations share electron acceptors/donors such as 50 
NAD(P)+/NAD(P)H to connect oxidative and reductive 
reactions. In an attempt to mimic such efficient natural 
processes, concurrent catalytic concepts are being developed 
for the synthesis of enantioenriched derivatives.14 A nice 
example of this methodology was recently developed,15 by 55 
using three biocatalysts to simultaneously obtain morphinone 
and hydromorphone with a dehydrogenase and a reductase, 
respectively. The critical step was the employment of a 
transhydrogenase that permitted the internal cofactor-
recycling necessary to achieve each transformation (NADH 60 
and NADPH). Herein we describe a methodology which 
allows the concurrent preparation of enantioenriched 
derivatives in a strict parallel fashion, thereby minimising the 
quantity of reagents employed and maximising the redox 
economy16 of the process by coupling two asymmetric 65 
transformations: a) via two kinetic resolutions or b) via a 
kinetic resolution and a desymmetrization reaction (Scheme 
1). By a proper selection of both catalysts (an ADH and a 
BVMO) and using a catalytic amount of coenzyme (which 
acts as connector) all possible enantiomers can be obtained in 70 
a one-pot process. xxx 
<Scheme 1 here> 
Scheme 1. Obtaining of enantioenriched compounds by interconnecting 
two asymmetric processes. 
Results and discussion 75 
When developing the system, several practical criteria were taken 
into consideration in advance. Since two different catalysts were 
used, parameters like pH, temperature or cofactor preference 
must be optimised to find compatible reaction conditions. 
Another criterion to take into account is that each substrate 80 
should be converted by only one of the biocatalysts, since an 
undesired side reaction would yield a by-product, and more 
importantly, an incomplete process as result of ineffective 
cofactor recycling (see below). 
As previously described, BVMOs catalyse irreversible 85 
oxidation processes at the expense of NADPH,17 while ADHs 
utilize NAD+ and/or NADP+. As these biocatalysts require 
stoichiometric amounts of the expensive NAD(P)H coenzyme, 
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we designed a coupled process that involves a BVMO-
catalysed oxidation and an ADH-catalysed oxidative kinetic 
resolution of a sec-alcohol, where the coenzyme will undergo 
internal recycling (Scheme 1a).18 Phenylacetone 
monooxygenase (PAMO)19 from Thermobifida fusca, its 5 
M446G mutant20 and 4-hydroxyacetophenone monooxygenase 
(HAPMO)21 from Pseudomonas fluorescens ACB were 
chosen as BVMOs due to their ability to catalyse 
enantioselective oxidations and to be readily obtainable in 
recombinant form.22 We selected two ADHs with the same 10 
coenzyme preference (NADP+) and opposite stereopreference: 
alcohol dehydrogenases from Lactobacillus brevis 
(LBADH)23 and from Thermoanaerobacter sp. (ADH-T).24 
Firstly, we studied the interconnected kinetic resolution of 
(±)-2-phenylpentan-3-one 1a22c and (±)-2-octanol 3a with the 15 
BVMO-ADH couple by using equimolar amounts of both 
compounds and a catalytic amount of the nicotinamide 
cofactor (Scheme 2 and Table 1). Initial experiments 
performed with HAPMO and ADH-T (entries 1-6) showed 
that the best reaction conditions were 20ºC and pH 7.5 (entry 20 
1), yielding (R)-1a and (S)-2a25 in a highly selective process 
(E ≥200).26 When higher temperatures or pHs were used, 
lower conversions and selectivities were obtained, which is 
probably due to inactivation of HAPMO22c and ADH-T. It is 
noteworthy that a catalytic amount of NADPH (0.2 mM) was 25 
sufficient to achieve a successful process. Due to the fact that 
ADH-T is a Prelog27 enzyme, (S)-3a was selectively oxidised 
to 4a, while remaining (R)-3a was obtained with high ee. 
When HAPMO was combined with LBADH at 20ºC and pH 
8.528 (entry 7), again an excellent double resolution was 30 
observed, although in this case alcohol (S)-3a was obtained. 
This shows that the selectivity of this system can simply be 
tuned by changing the employed biocatalysts. 
Reactions were also carried out using PAMO as biocatalyst 
(entries 8-16). As shown in entry 8, when this enzyme was 35 
employed in combination with ADH-T, (R)-1a, (S)-2a and 
(R)-3a were achieved with conversions close to 50% in a 
process with excellent selectivity. The coupled system 
PAMO-LBADH was analysed in order to determine the best 
reaction conditions. The effect of pH when conducting the 40 
oxidations with PAMO at 20ºC was studied (entries 9-12), 
obtaining the best conditions for the resolution at pH 8.5-9.0. 
Higher pHs produced a loss in both activity and selectivity 
(entry 12). Once established pH 8.5 as the optimum for this 
system, the effect of the temperature was determined. 45 
Reactions could be performed at 30-40ºC with excellent 
selectivities and good conversions (entries 13-14), while a 
further increase of the temperature at 50ºC led to a loss in 
selectivity (E= 29, entry 15) and finally an important decrease 
in the activity at 60ºC (entry 16). It is important to note that 50 
the system can even work at this high temperature. 
Surprisingly, in some cases traces of n-hexyl acetate 
derivative 5a were detected.29 This product is formed in a 
cascade process by the ADH-catalysed oxidation of (±)-3a to 
2-octanone 4a followed by its BVMO-catalysed oxidation 55 
(Scheme 2). 
Concurrent catalysis is relatively demanding since all the 
steps should work at similar rates to ensure appropriate 
transformations.6b In this particular case, two asymmetric 
transformations are truly occurring in a parallel way. If the 60 
reaction conditions are not appropriate, even for only one of 
the processes, both reactions will not be completed due to the 
fact that they are connected by a recycling agent (in this case 
the nicotinamide coenzyme) which is the key to the whole 
system outcome. Considering the above mentioned features, 65 
this type of processes could be described as parallel 





<Scheme 2 here> 
Scheme 2. Concurrent kinetic resolutions of (±)-1 and (±)-3 employing BVMOs and ADHs. Esters 5 are obtained as by-products through a cascade 
process. 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  3 
Table 1. Enzymatic kinetic resolution of racemic ketone 1a and (±)-2-octanol 3a by using BVMOs and ADHs in a concurrent way.a 
Entry BVMO ADH pH T (ºC) ee 1a (%)b ee 2a (%)b c (%)c Ed ee 3a (%)b 3a (%)b 4a (%)b 5a (%)b 
1 HAPMO T 7.5 20 87 97 47 ≥200 53 (R) 46 51 4 
2 HAPMO T 8.0 20 73 97 44 144 53 (R) 47 50 3 
3 HAPMO T 8.5 20 57 97 37 102 58 (R) 38 60 2 
4 HAPMO T 10 20 6 81 10 11 10 (R) 10 90 -- 
5 HAPMO T 8.5 25 39 94 35 51 53 (R) 35 65 -- 
6 HAPMO T 8.5 30 17 92 20 29 25 (R) 21 79 -- 
7 HAPMO LB 8.5 20 92 98 48 ≥200 92 (S) 44 52 4 
8 PAMO T 7.5 20 85 96 47 147 97 (R) 50 50 -- 
9 PAMO LB 7.5 20 46 98 32 118 45 (S) 32 68 -- 
10 PAMO LB 8.5 20 99 93 52 145 98 (S) 48 50 2 
11 PAMO LB 9.0 20 91 96 49 156 98 (S) 50 50 -- 
12 PAMO LB 10.0 20 40 97 29 66 41 (S) 30 70 -- 
13 PAMO LB 8.5 30 90 97 48 160 98 (S) 50 50 -- 
14 PAMO LB 8.5 40 70 96 42 106 61 (S) 38 62 -- 
15 PAMO LB 8.5 50 50 89 36 29 64 (S) 39 59 2 
16 PAMO LB 8.5 60 26 92 21 30 27 (S) 19 79 2 
a Reaction time: 24 h. For other reaction details, see Experimental Section. b Measured by GC. c Conversion, c= ees/(ees+eep). 
d Enantomeric ratio, E= 
ln{(1-ees)/[1+(ees/eep)]}/ln{(1+ees)/[1+(ees/eep)]}. 
 
Once the best process conditions had been established at pH 5 
8.5 and 20ºC, we studied the system with other substrates 
(Table 2). In a first set of experiments, (±)-alcohol 3a was 
exchanged by using (±)-2-undecanol 3b or (±)-sulcatol 3c in 
combination with (±)-1a employing BVMOs and ADHs 
(entries 1-8). It was observed that using (±)-3b with PAMO 10 
(entries 3 and 4) yielded better conversions and 
enantioselectivities than with HAPMO (entries 1 and 2), and 
interestingly, also a smaller amount of ester 5b (n-nonyl 
acetate)29 was produced. When alcohol (±)-3c was used, the 
resolution of (±)-1a was excellent, but depending on the ADH 15 
employed the obtained ee for 3c varied. Thus, LBADH 
afforded enantiopure (S)-3c (entries 6 and 8) while ADH-T 
yielded the alcohol with low optical purity (entries 5 and 7). 
Control reactions incubating alcohols (±)-3a-c with ADH-T 
and an excess of acetone showed that 3a and 3b were 20 
enantioselectively oxidised yielding the corresponding (R)-
alcohols. On the other hand, (±)-sulcatol was oxidised with a 
conversion higher than 95%, indicating that ADH-T was not 
able to differentiate between both enantiomers of alcohol 3c. 
As described for (±)-2-undecanol, a lower quantity of ester 25 
5c28 was obtained when PAMO was used instead of HAPMO. 
Another ketone such as 4-phenylhexan-3-one (±)-1b was also 
resolved in the presence of (±)-2-octanol 3a obtaining 
excellent enantioselectivities (E≥ 200 in all cases) and high 
ees for alcohol 3a25 (entries 9 to 12). For all the tested 30 
enzymes, only traces of n-hexyl acetate 5a were observed. To 
demonstrate the applicability of this system, this reaction was 
also performed at a 20-fold larger scale obtaining enantiopure 
(R)-1b and (R)-3a with 50% conversion and good yields. 
Other experiments were carried out to demonstrate that both 35 
reactions must efficiently proceed to achieve an adequate 
system. Starting from an appropriate model, i.e. (±)-1a and 
(±)-3a, one of these compounds was exchanged by a poor 
substrate for one of the enzymes. Thus, racemic 1a was 
combined with 2-tetralol (±)-3d using ADH-T with the 40 
BVMOs. In both cases less than 3% of ester 2a was obtained 
after 24 h. When (±)-1a was substituted by (±)-2-
phenylheptan-3-one 1c in the reaction catalysed by PAMO 
and both ADHs in the presence of (±)-2-octanol, the Baeyer-
Villiger oxidation of ketone 1c did not work (only 5% of ester 45 
2c). However, the ADH-catalysed oxidation of 3a to 4a 
followed by cofactor regeneration provided by the BVMO-
catalysed oxidation of 4a to 5a, allowed the resolution of (±)-
3a obtaining 46% of enantiopure (S)-3a when LBADH was 
employed. Furthermore, we observed the formation of ketone 50 
4a (6%) during production of 2c. When ADH-T was applied 
as biocatalyst, 8% of 2-octanone 4a (due to formation of 2c) 
and 92% of 5a were obtained, since this ADH was able to 
oxidise both enantiomers of 3a. 
In this approach, formation of final products (2 and 4) must be 55 
equal along the reaction course. If both resolutions exhibit 
similar enantioselectivities, remaining substrate ees (1 and 3), 
should be similar during the whole process. In order to verify 
this, we monitored the double kinetic resolution of (±)-1b and 
(±)-3a catalysed by PAMO and ADH-T (Figure 1). As can be 60 
seen, percentages of ester 2b and ketone 4a were nearly the 
same during the whole experiment. Furthermore, ee values of 
remaining (R)-1b and (R)-3a remained similar. After 6 hours, 
(R)-1b and 4a were slowly oxidised into the corresponding 
esters.  65 
<Figure 1 here> 
Figure 1. Time study of the concurrent enzymatic resolution of (±)-1b 
and (±)-3a using PAMO and ADH-T. Percentage of: 2b (♦); 4a (□); 5a 
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Table 2. Parallel interconnected kinetic resolutions of racemic ketones and sec-alcohols by combining BVMOs and ADHs.a 
Entry BVMO ADH ketone alcohol t (h) ee 1 (%)b ee 2 (%)b c (%)c Ed ee 3 (%)b 3 (%)b 4 (%)b 5 (%)b 
1 HAPMO T (±)-1a (±)-3b 24 66 97 48 144 73 (R) 35 57 8 
2 HAPMO LB (±)-1a (±)-3b 24 52 97 46 114 66 (S) 33 59 8 
3 PAMO T (±)-1a (±)-3b 24 64 96 46 145 87 (R) 48 52 -- 
4 PAMO LB (±)-1a (±)-3b 24 99 89 53 132 99 (S) 49 50 1 
5 HAPMO T (±)-1a (±)-3c 24 99 99 50 ≥200 3 (R) 38 50 12 
6 HAPMO LB (±)-1a (±)-3c 24 99 95 51 ≥200 99 (S) 46 46 8 
7 PAMO T (±)-1a (±)-3c 24 93 96 48 179 21 (R) 48 50 2 
8 PAMO LB (±)-1a (±)-3c 24 98 96 50 ≥200 99 (S) 48 50 2 
9 HAPMO T (±)-1b (±)-3a 24 75 99 43 ≥200 76 (R) 41 57 2 
10 HAPMO LB (±)-1b (±)-3a 24 87 99 47 ≥200 99 (S) 50 50 -- 
11 PAMO T (±)-1b (±)-3a 6 99 96 50 ≥200 93 (R) 49 49 2 
12 PAMO LB (±)-1b (±)-3a 4.5 72 98 41 ≥200 71 (S) 42 58  
a For reaction details, see Experimental Section. b Measured by GC. c Conversion, c= ees/(ees+eep). 
d Enantomeric ratio, E= 
ln{(1-ees)/[1+(ees/eep)]}/ln{(1+ees)/[1+(ees/eep)]}. 
 5 
<Scheme 3 here> 
Scheme 3. Stereodivergent concurrent preparation of sulfoxide 7 and sec-alcohol 3 using this methodology (t= 24 h). 
As BVMOs can catalyse the selective oxidation of different 
heteroatoms, we explored the stereodivergent and 
simultaneous preparation of enantioenriched methyl phenyl 10 
sulfoxide (7) and alcohol 3a starting from prochiral 
thioanisole (6) and (±)-3a (Schemes 1b and 3). For this, we 
used either HAPMO, which selectively oxidised thioanisole to 
(S)-7,30 or mutant M446G PAMO, which is able to catalyse 
the preparation of (R)-7,20 in combination with LBADH or 15 
ADH-T. As shown in Scheme 3, both compounds were 
achieved with excellent conversions and selectivities, and 
depending on the pair of catalysts employed we could obtain 
all possible stereoisomer pairs. Only small amounts of n-hexyl 
acetate 5a were formed (≤5%), and interestingly, no methyl 20 
phenyl sulfone was detected. Therefore, by simply tuning the 
biocatalysts employed, enantiocomplementary products could 
be easily obtained. 
For a better understanding of the obtained ratios 2a-b/5a-c 
and 5a/7, the steady-state kinetic parameters of BVMOs 25 
toward substrates 1a-b, 4a-c and 6 were determined. BVMOs 
clearly preferred racemic ketones (±)-1a-b and sulfide 6 when 
compared with compounds 4a-c. 
Table 3. Kinetic parameters for the Baeyer-Villiger oxidation of ketones 
(±)-1a-b, (±)-4a-c and sulfide 6. 30 
Compound BVMO KM (mM) kcat (s
-1) kcat/KM (M
-1 s-1) 
(±)-1a PAMO 0.03 2.90 96,700 
(±)-1a HAPMO 4.0 14.15 3,500 
(±)-1b PAMO 0.02 2.54 127,000 
(±)-1b HAPMO 0.10 4.06 40,600 
(±)-4a PAMO 0.23 0.39 1,700 
(±)-4a HAPMO 1.0 1.48 1,480 
(±)-4a M446G 1.34 0.25 190 
(±)-4b PAMO 0.07 0.37 5,300 
(±)-4b HAPMO 0.02 3.54 177,000 
(±)-4c PAMO 2.5 1.70 680 
(±)-4c HAPMO 1.3 0.39 300 
6 HAPMO 0.36 3.02 8,400 
6 M446G 1.00 0.90 900 
 
 
As shown in Table 3, and in accordance with the 
interconnected system results, PAMO and HAPMO showed 
different kinetic profiles. When comparing the data obtained 35 
with PAMO, it is interesting to note that KM values display a 
relatively large variance, while kcat values for all substrates 
are in the same range. This observation was already noted in 
previous studies with this BVMO and suggested that the 
maximal turnover rate did not depend on the chemical nature 40 
of the substrate.17,22c On the contrary, a wide range of kcat 
(from 0.39 to 14.15 s-1) and KM (from 0.02 to 4.0 mM) values 
were observed with HAPMO. These enzymes (in particular 
HAPMO) showed an acceptable catalytic efficiency towards 
aliphatic ketones 4a-c, which explains the amount of acetates 45 
5 obtained in these reactions. Despite the high catalytic 
efficiency, 2-undecanone 4b showed inhibition of HAPMO 
activity at high substrate concentrations (>5 mM). 
Interestingly, although the catalytic efficiencies of both 
processes are rather different (the Baeyer-Villiger oxidation 50 
appeared as the rate limiting step), the transformations occur 
in a strict parallel fashion due to the NADP+/NADPH loop. 
Thus, the Baeyer-Villiger oxidation is the rate limiting step in 
our system considering the high catalytic efficiency of ADHs 
with the selected alcohols. In case of LBADH, 2-octanol was 55 
oxidised in 50 mM Tris-HCl buffer pH 8.5 at 41 s-1 and 
showed a KM value of 0.29 mM. 
Conclusions 
In this report we describe an integrated coenzyme 
regeneration cycle which allows parallel interconnected 60 
kinetic asymmetric transformations. By using this 
methodology, we could simultaneously obtain enantiopure 
compounds (via kinetic resolution or desymmetrization) and 
minimise the quantity of reagents employed. The reported 
one-pot reactions are performed using two biocatalysts and a 65 
catalytic amount of nicotinamide cofactor which is internally 
recycled and acts as a connector between both processes. They 
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strictly occur in parallel and at least one of the 
transformations must be (quasi)irreversible to ensure good 
results. In addition, the selectivity of this system can simply 
be tuned by changing the employed biocatalysts. As a 
consequence, the selection of catalysts, connector, and 5 
substrates must be carefully taken into account.  
We have shown that the kinetic properties of the biocatalysts  
support the obtained experimental results. Both BVMOs 
prefer aromatic compounds (±)-1a and (±)-1b over aliphatic 
ketones 4a-c. Interestingly, the oxidation of these latter 10 
compounds by BVMOs is also possible, opening new 
possibilities in order to oxidise such derivatives. We have 
demonstrated that this procedure is not only feasible with 
enantioselective Baeyer-Villiger oxidations but also with 
asymmetric sulfoxidations. This system shows the possibility 15 
of controlling biocatalytic processes in parallel with a defined 
purpose as occurs in nature. 
Experimental 
PAMO, its M446G mutant and HAPMO were overexpressed 
and purified according to previously described methods.19-21 20 
The oxidation reactions were performed using purified 
enzymes or cell free extract preparations of the corresponding 
overexpressed enzyme. One unit (U) of Baeyer-Villiger 
monooxygenase (BVMO) oxidises 1.0 mol of 2-
phenylpentan-3-one 1a to 1-phenylethyl propionate 2a per 25 
minute at pH 8.0 and 20ºC in the presence of NADPH. 
Alcohol dehydrogenases from Lactobacillus brevis ADH 
(LBADH) and Thermoanaerobacter sp. ADH (ADH-T) were 
purchased from commercial sources. The amount of ADH 
used in the different assays was calculated according to the 30 
activity data provided by the supplier (ADH-T 780 U mL-1, 
LBADH 2,320 U mL-1). Racemic alcohols (±)-3a-3d, ketones 
4a-4d, methyl phenyl sulfide (6), racemic phenyl methyl 
sulfoxide [(±)-7] as well as other reagents and solvents were 
of the highest quality grade available, supplied by Sigma-35 
Aldrich-Fluka. Racemic compounds (±)-1a-1c were prepared 
according to the literature.31 Racemic esters (±)-2a-2c were 
synthesised by acylation of commercial 1-phenylethanol or 1-
phenylpropanol using propionic or valeric anhydride (yields 
higher than 80%). Compounds 5a-5c were prepared by 40 
conventional acetylation of the corresponding primary 
alcohols using acetic anhydride and DMAP. 
Flash chromatography was performed using Merck silica gel 
60 (230-400 mesh). IR spectra were recorded on a Perkin-
Elmer 1720-X infrared Fourier transform spectrophotometer 45 
using KBr pellets. 1H NMR, 13C NMR and DEPT spectra were 
recorded with TMS (tetramethylsilane) as the internal 
standard with a Bruker AC-300-DPX (1H, 300.13 MHz and 
13C, 75.4 MHz) spectrometer. The chemical shift values (δ) 
are given in ppm and the coupling constants (J) in Hertz (Hz). 50 
For ESI+, a HP 1100 chromatograph mass detector and for EI+ 
a Finigan MAT 95 spectrometer were used to record mass 
spectra (MS). GC analyses were performed on a Hewlett 
Packard 6890 Series II chromatograph. HPLC analyses were 
developed with a Hewlett Packard 1100 LC liquid 55 
chromatograph. 
General procedure for the enzymatic resolution of racemic 
ketones and alcohols catalysed by BVMOs and ADHs 
Racemic ketones (±)-1a-b (10-15 mM) were dissolved in a 
Tris-HCl buffer (50 mM, different pHs, 0.5 mL). Then, 60 
NADPH (0.2 mM), the corresponding ADH (2 U), HAPMO or 
PAMO (2 U), and racemic alcohols (±)-3a-c (1 equiv.) were 
added. When LBADH was used, magnesium chloride (final 
concentration, 1 mM) was added to the reaction medium. The 
mixture was shaken at 250 rpm at selected temperatures. The 65 
reaction was stopped by extraction with ethyl acetate (2 x 0.5 
mL) and the organic layer was dried over Na2SO4. 
Conversions and enantiomeric excesses of compounds 1a-b, 
2a-b, 3a-c, 4a-c, and 5a-c were determined by GC analysis. 
Reaction of ketone (±)-1a and alcohol (±)-3a using PAMO and 70 
ADH-T as biocatalysts at multimilligram scale 
Ketone 1a (25 mg, 11.3 mM) was dissolved in a Tris-HCl 
buffer (50 mM, pH 7.5, 12.5 mL). Then, NADPH (0.2 mM), 
ADH-T (20 U), PAMO (20 U), and racemic alcohol 3a (22.5 
µL, 11.3 mM) were added. The mixture was shaken at 20ºC 75 
and 250 rpm for 6 h. Then, the reaction was stopped by 
extraction with ethyl acetate (5 x 5 mL) and the organic layer 
was dried over Na2SO4. Afterwards, the organic solvents and 
remanent ketone 4a were removed under reduced pressure and 
the crude residue was purified using flash chromatography 80 
(hexane:CH2Cl2 1:1) obtaining enantiopure (R)-1a (10.1 mg, 
81% yield), (S)-2a (11.7 mg, 86% yield), and (R)-3a (7.0 mg, 
75% yield). Chemical purity of reaction products was 
determined by both GC and NMR. 
General procedure for the oxidation of thioanisole and (±)-2-85 
octanol catalysed by BVMOs and ADHs 
Sulfide 6 (14.5 mM) was added to Tris-HCl buffer (50 mM, 
pH 7.5, 0.5 mL) containing 1% v v-1 DMSO. Then, NADPH 
(0.2 mM), the corresponding ADH (2 U), HAPMO (2 U), and 
racemic alcohol 3a (30 mM) were added. When LBADH was 90 
used, magnesium chloride (1 mM, final concentration) was 
added to the reaction medium. The mixture was shaken at 
30ºC and 250 rpm for 24 h. Then, the reactions were stopped 
by extraction with ethyl acetate (2 x 0.5 mL) and the organic 
layer was dried over Na2SO4. Conversions and enantiomeric 95 
excesses of final compounds were determined by GC and 
HPLC analysis. 
 
HAPMO-catalysed sulfoxidation of thioanisole (6) coupled 
with the kinetic resolution of (±)-2-octanol (3a) catalysed by 100 
LBADH 
Sulfide 6 (20 mg, 23 mM) was added into a preparation of cell 
free extract (in Tris-HCl buffer 50 mM pH 7.5) from 
recombinant E. coli TOP10 overexpressing HAPMO (7 mL, 
with a total protein concentration of approx. 10 mg mL -1 105 
containing 1% v v-1 DMSO). Then, NADPH (0.2 mM), MgCl2 
(1 mM), LBADH (20 U), and racemic 2-octanol 3a (54 µL, 47 
mM) were added. The mixture was shaken at 20ºC and 250 
rpm for 24 h. Then, the reaction was stopped by extraction 
with diethyl ether (5 x 5 mL) and the organic layer was dried 110 
over Na2SO4. Afterwards, the organic solvents were carefully 
removed under reduced pressure at low temperature and the 
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crude residue was purified using flash chromatography 
(hexane:CH2Cl2 mixtures of increasing polarities) obtaining 
enantiopure (S)-7 (18.5 mg, 84% isolated yield) and (S)-3a 
(20 µL, 74% isolated yield). Chemical purity of reaction 
products was determined by both GC and NMR. 5 
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